Document is current
Any future updates will be listed below
-
Authors
Diaz-Hurtado, Marcos http://orcid.org/0000-0003-1528-5873
MartÃnez-Heras, Eloy http://orcid.org/0000-0001-9937-3162
Solana, Elisabeth http://orcid.org/0000-0001-7973-2439
Casas-Roma, Jordi http://orcid.org/0000-0002-0617-3303
Llufriu, Sara http://orcid.org/0000-0003-4273-9121
Kanber, Baris http://orcid.org/0000-0003-2443-8800
Prados, Ferran http://orcid.org/0000-0002-7872-0142
- License Information
-
More Information
Article History
Received: 29 March 2022
Accepted: 12 July 2022
First Online: 22 July 2022
Declarations
:
: M.D.-H., E.M.-H., J.C.-R., B.K. and F.P. have nothing to disclose. E.S received travel reimbursement from Sanofi. S.L. received compensation for consulting services and speaker honoraria from Biogen Idec, Novartis, TEVA, Genzyme, Sanofi and Merck.
: This study has been approved by the Ethics Committee of the University Oberta de Catalunya (UOC) stating that this research does not include human subject participation or any processing of personal data and the research fulfils current legislation on data protection.
: This research does not include human subject participation or any processing of personal data.
: All authors consent for publication of this paper.
